Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2012

View Archived Issues

Shionogi reports on first quarter of 2012

Synthetic Biologics to use Intrexon technology for mAb development

Genkyotex product attenuates liver fibrosis in vivo

University of Queensland researcher receives grant for nanoparticle delivery system

Novel computational method pairs known drugs with new uses

Researchers describe vaccine's cross-reactivity against Nipah virus

Abbott designs novel ALK blockers

Research at Actelion yields new S1P1 receptor agonists

Actinium and Philogen partner to develop adhesion-targeted anticancer radiotherapies

Dutch regulatory agency denies approval of Cortiment

New HDAC8/HDAC6 inhibitors patented

Salix and Alfa Wassermann enter agreement for EIR rifaximin formulation

FDA requests new validated test system for immunoglobulin preparation

McGill University presents new antibiotics

Topically delivered nanoparticle-siRNA conjugates suppress gene expression in vivo

Astellas and AstraZeneca gain approval in Japan for COPD therapeutic

Novel beta-secretase inhibitors created at Eisai

Japanese MHLW approves Bactramin/Baktar for additional indication

Humira approved for additional indication in Japan

Acquisition of Amylin Pharmaceuticals complete

AnaMar to conduct phase II studies of new analgesic and anti-inflammatory drug

Clovis Oncology launches CP-4126 combination trial

Galenea and CHDI Foundation extend and expand Huntington's disease collaboration

Nodality and Pfizer enter multiyear strategic collaboration

Sunitinib capsules approved in Japan for treatment of pancreatic neuroendocrine tumors

Japanese authorities grant new approval to ultrasound contrast agent

Flagyl approved for additional indication in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...